Capricor Therapeutics Price to Book Ratio 2012-2026 | CAPR
Historical price to book ratio values for Capricor Therapeutics (CAPR) over the last 10 years. The current price to book ratio for Capricor Therapeutics as of September 17, 2026 is 2.22.
| Capricor Therapeutics Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2026-09-18 | 9.06 | 2.14 | |
| 2026-06-30 | 24.08 | $4.24 | 5.68 |
| 2026-03-31 | 30.40 | $4.83 | 6.29 |
| 2025-12-31 | 28.86 | $5.33 | 5.41 |
| 2025-09-30 | 7.21 | $1.83 | 3.93 |
| 2025-06-30 | 9.93 | $2.30 | 4.32 |
| 2025-03-31 | 9.49 | $2.79 | 3.40 |
| 2024-12-31 | 13.80 | $3.19 | 4.32 |
| 2024-09-30 | 15.21 | $1.69 | 8.99 |
| 2024-06-30 | 4.77 | $0.36 | 13.26 |
| 2024-03-31 | 6.79 | $0.58 | 11.64 |
| 2023-12-31 | 4.89 | $0.73 | 6.74 |
| 2023-09-30 | 3.42 | $-0.07 | -49.49 |
| 2023-06-30 | 4.78 | $0.11 | 45.09 |
| 2023-03-31 | 4.22 | $0.25 | 17.18 |
| 2022-12-31 | 3.86 | $0.47 | 8.27 |
| 2022-09-30 | 6.00 | $0.62 | 9.61 |
| 2022-06-30 | 3.49 | $0.77 | 4.53 |
| 2022-03-31 | 3.43 | $1.01 | 3.39 |
| 2021-12-31 | 2.93 | $1.30 | 2.26 |
| 2021-09-30 | 4.02 | $1.52 | 2.64 |
| 2021-06-30 | 5.13 | $1.45 | 3.53 |
| 2021-03-31 | 4.68 | $1.60 | 2.93 |
| 2020-12-31 | 3.43 | $1.37 | 2.50 |
| 2020-09-30 | 5.25 | $1.50 | 3.49 |
| 2020-06-30 | 4.60 | $1.61 | 2.86 |
| 2020-03-31 | 1.20 | $1.04 | 1.15 |
| 2019-12-31 | 1.28 | $1.31 | 0.98 |
| 2019-09-30 | 3.70 | $0.86 | 4.33 |
| 2019-06-30 | 3.32 | $0.68 | 4.87 |
| 2019-03-31 | 4.70 | $1.11 | 4.23 |
| 2018-12-31 | 4.10 | $1.47 | 2.79 |
| 2018-09-30 | 10.50 | $2.27 | 4.63 |
| 2018-06-30 | 13.40 | $3.21 | 4.17 |
| 2018-03-31 | 13.60 | $3.77 | 3.61 |
| 2017-12-31 | 15.80 | $4.27 | 3.70 |
| 2017-09-30 | 30.30 | $-1.70 | -17.81 |
| 2017-06-30 | 8.30 | $-2.92 | -2.85 |
| 2017-03-31 | 33.80 | $-3.36 | -10.06 |
| 2016-12-31 | 26.60 | $-1.87 | -14.22 |
| 2016-09-30 | 32.40 | $0.02 | 1408.70 |
| 2016-06-30 | 39.50 | $-2.85 | -13.86 |
| 2016-03-31 | 25.40 | $-0.60 | -42.11 |
| 2015-12-31 | 30.70 | $-0.63 | -48.37 |
| 2015-09-30 | 40.50 | $1.18 | 34.19 |
| 2015-06-30 | 50.50 | $2.81 | 17.98 |
| 2015-03-31 | 86.20 | $4.52 | 19.09 |
| 2014-12-31 | 37.50 | $-5.34 | -7.03 |
| 2014-09-30 | 38.50 | $-3.82 | -10.08 |
| 2014-06-30 | 44.00 | $-2.64 | -16.68 |
| 2014-03-31 | 85.00 | $-1.42 | -59.88 |
| 2013-12-31 | 32.50 | $-0.46 | -71.02 |
| 2013-09-30 | 25.00 | $-18.01 | -1.39 |
| 2013-06-30 | 25.00 | $-14.31 | -1.75 |
| 2013-03-31 | 50.00 | $-7.46 | -6.70 |
| 2012-12-31 | 25.00 | $4.73 | 5.29 |
| 2012-09-30 | 55.00 | $0.32 | 173.94 |
| 2012-06-30 | 50.00 | $6.30 | 7.94 |
| 2012-03-31 | 250.00 | $2.90 | 86.09 |
| 2011-12-31 | 275.00 | $10.46 | 26.29 |
| 2011-09-30 | 315.00 | $29.88 | 10.54 |
| 2011-06-30 | 390.00 | $41.15 | 9.48 |
| 2011-03-31 | 410.00 | $24.13 | 16.99 |
| 2010-12-31 | 310.00 | $37.49 | 8.27 |
| 2010-09-30 | 315.00 | $47.70 | 6.60 |
| 2010-06-30 | 165.00 | $68.32 | 2.41 |
| 2010-03-31 | 490.00 | $27.37 | 17.90 |
| 2009-12-31 | 605.00 | $55.05 | 10.99 |
| 2009-09-30 | 820.00 | $73.78 | 11.11 |
| 2009-06-30 | 460.00 | $37.55 | 12.25 |
| 2009-03-31 | 245.00 | $72.14 | 3.40 |
| 2008-12-31 | 425.00 | $105.67 | 4.02 |
| 2008-09-30 | 2015.00 | $155.09 | 12.99 |
| 2008-06-30 | 2625.00 | $210.98 | 12.44 |
| 2008-03-31 | 2300.00 | $271.95 | 8.46 |
| 2007-12-31 | 2750.00 | $315.35 | 8.72 |
| 2007-09-30 | 2150.00 | $358.21 | 6.00 |
| 2007-06-30 | 1025.00 | $-0.22 | -4598.47 |
| 2007-03-31 | 1315.00 | $-0.19 | -6834.72 |
| 2006-12-31 | 4.00 | $-0.18 | -22.38 |
| 2006-09-30 | 7.50 | $-8.26 | -0.91 |
| 2006-03-31 | 6.90 | $-5.48 | -1.26 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.548B | $0.022B |
| Capricor Therapeutics, Inc. is a biotechnology company. It is focused on the development of novel therapeutics to prevent and treat heart disease. The Company has two drug candidates in development: Cenderitide and CU-NP. Capricor Therapeutics, Inc., formerly known as Nile Therapeutics, Inc., is based in San Mateo, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $176.897B | 19.43 |
| Medtronic (MDT) | Ireland | $118.666B | 16.22 |
| Stryker (SYK) | United States | $107.450B | 20.08 |
| EssilorLuxottica (ESLOY) | France | $75.078B | 0.00 |
| Boston Scientific (BSX) | United States | $63.114B | 13.57 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.379B | 0.00 |
| Agilent Technologies (A) | United States | $44.077B | 25.80 |
| Medline (MDLN) | United States | $42.228B | 0.00 |
| ResMed (RMD) | United States | $32.950B | 20.45 |
| GE HealthCare Technologies (GEHC) | United States | $29.109B | 13.92 |
| Koninklijke Philips (PHG) | Netherlands | $24.258B | 12.92 |
| Terumo (TRUMY) | Japan | $21.654B | 20.68 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.977B | 11.11 |
| Baxter (BAX) | United States | $11.901B | 11.23 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.666B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $10.225B | 41.21 |
| Demant (WILYY) | Denmark | $10.101B | 0.00 |
| Insulet (PODD) | United States | $9.817B | 24.11 |
| Sunny Optical Technology (SNPTF) | China | $9.508B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.579B | 20.24 |
| BillionToOne (BLLN) | United States | $5.222B | 158.10 |
| Raia Drogasil SA - (RADLY) | Brazil | $5.122B | 0.00 |
| Haemonetics (HAE) | United States | $4.895B | 21.48 |
| DiaSorin S.p.A (DSRLF) | Italy | $4.705B | 0.00 |
| ICU Medical (ICUI) | United States | $3.822B | 22.82 |
| Envista Holdings (NVST) | United States | $3.805B | 16.12 |
| AtriCure (ATRC) | United States | $3.007B | 257.04 |
| Neogen (NEOG) | United States | $2.798B | 49.35 |
| Curaleaf Holdings (CURLF) | United States | $2.396B | 0.00 |
| Curaleaf Holdings (CURLD) | Canada | $2.388B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.288B | 0.00 |
| Trulieve Cannabis (TRLV) | United States | $2.243B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $2.201B | 10.51 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.888B | 0.00 |
| Perrigo (PRGO) | Ireland | $1.871B | 5.39 |
| LeMaitre Vascular (LMAT) | United States | $1.817B | 29.22 |
| BioLife Solutions (BLFS) | United States | $1.803B | 230.31 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $1.798B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.450B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.436B | 15.31 |
| Phibro Animal Health (PAHC) | United States | $1.399B | 10.73 |
| Omeros (OMER) | United States | $1.336B | 6.76 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.107B | 0.00 |
| CeriBell (CBLL) | United States | $0.959B | 0.00 |
| InMode (INMD) | Israel | $0.836B | 11.63 |
| AdaptHealth (AHCO) | United States | $0.785B | 16.46 |
| VAREX IMAGING (VREX) | United States | $0.781B | 17.17 |
| QuidelOrtho (QDEL) | United States | $0.761B | 8.21 |
| Glass House Brands (GLAS) | United States | $0.749B | 0.00 |
| Valneva SE (VALN) | France | $0.623B | 0.00 |
| Brainsway (BWAY) | Israel | $0.544B | 30.75 |
| Vireo Growth (VREOF) | United States | $0.540B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.537B | 0.00 |
| Cerus (CERS) | United States | $0.536B | 0.00 |
| Evolus (EOLS) | United States | $0.529B | 0.00 |
| Vireo Growth (VREOD) | United States | $0.451B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.446B | 0.00 |
| Verano Holdings (VRNOD) | United States | $0.425B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.422B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.395B | 8.28 |
| Cresco Labs (CRLBF) | United States | $0.367B | 0.00 |
| SNDL (SNDL) | Canada | $0.350B | 0.00 |
| Village Farms (VFF) | Canada | $0.347B | 15.78 |
| Viemed Healthcare (VMD) | United States | $0.341B | 24.86 |
| Sanara MedTech (SMTI) | United States | $0.321B | 159.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.302B | 0.00 |
| MacroGenics (MGNX) | United States | $0.263B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.250B | 13.28 |
| OraSure Technologies (OSUR) | United States | $0.241B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.236B | 22.62 |
| High Tide (HITI) | Canada | $0.236B | 53.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| TerrAscend (TSNDF) | Canada | $0.201B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.194B | 0.00 |
| Exagen (XGN) | United States | $0.191B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Jin Medical (ZJYL) | China | $0.155B | 0.00 |
| Organigram Global (OGI) | Canada | $0.151B | 0.00 |
| Quanterix (QTRX) | United States | $0.148B | 0.00 |
| Apyx Medical (APYX) | United States | $0.128B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.53 |
| ImmuCell (ICCC) | United States | $0.091B | 124.75 |
| FitLife Brands (FTLF) | United States | $0.090B | 11.77 |
| Jushi Holdings (JUSHF) | United States | $0.083B | 0.00 |
| Accendra Health (ACH) | United States | $0.079B | 4.48 |
| Sharps Technology (STSS) | United States | $0.065B | 0.00 |
| InterCure (INCR) | Israel | $0.058B | 0.00 |
| Hongchang (HCIL) | China | $0.055B | 0.00 |
| Biote (BTMD) | United States | $0.049B | 3.97 |
| Nephros (NEPH) | United States | $0.046B | 38.46 |
| Veru (VERU) | United States | $0.041B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.036B | 17.21 |
| United-Guardian (UG) | United States | $0.033B | 13.39 |
| Rockwell Medical (RMTI) | United States | $0.032B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.023B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.018B | 0.00 |
| Modular Medical (MODD) | United States | $0.018B | 0.00 |
| Bonk (BNKK) | United States | $0.011B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.006B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Agape ATP (ATPC) | $0.002B | 0.00 | |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.000B | 0.00 |
| INLIF (INLF) | China | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |